Bubs Australia (ASX:BUB) — Material Events
ASX:BUB · 8 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Bubs Australia Boosts Revenue 30% with Strong US Growth and Positive EBITDAMedium
Bubs Australia posts 30% revenue growth in Q1 FY26 with positive EBITDA and strong USA performance
31 Oct 2025
·Quarterly Activities Report and Appendix 4C
·85
Bubs Australia Surges on US Growth, Lifts FY26 Earnings OutlookMedium
Bubs Australia posts strong 1HY26 results, upgrades FY26 earnings guidance
27 Feb 2026
·Financial Results
·85
Bubs Australia’s US Surge Drives 14% Revenue Rise in H1 FY26Medium
Bubs Australia H1 FY26 revenue up 14% led by US growth; FDA approval on track
30 Jan 2026
·Quarterly Activities Report and Appendix 4C Cashflow Statement
·80
Bubs Australia Elevates Paul Jensen to Chair, Welcomes Joe Coote as CEOMedium
Bubs Australia appoints new Chair Paul Jensen and CEO Joe Coote
15 Sept 2025
·Board and Executive Change
·70
Bubs Australia Flags FY26 Revenue $105M-$115M Amid Supply and Geopolitical HeadwindsMedium
Bubs Australia FY26 revenue guidance $105 - 115M; underlying EBITDA $4 - 8M amid external headwinds
29 May 2026
·Trading Update
·70
Bubs Australia Secures $825K Recovery Amid Legal Dispute ClosureMedium
Bubs Australia to recover A$825,000 from Willis in legal dispute, no further recoveries expected
6 Nov 2025
·Legal Update
·50
No articles in this tier for the last 12 months.